140 related articles for article (PubMed ID: 17878195)
1. No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up.
Liedorp M; Sanchez E; van Hoogstraten IM; von Blomberg BM; Barkhof F; Polman CH; Killestein J
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1146-8. PubMed ID: 17878195
[TBL] [Abstract][Full Text] [Related]
2. [Antiphospholipid syndrome and multiple sclerosis: differential-diagnostic aspects].
Spirin NN; Pizova NV; Stepanov IO
Zh Nevrol Psikhiatr Im S S Korsakova; 2002; Suppl():42-5. PubMed ID: 12418391
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
Przepiera-Będzak H; Brzosko M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):305-306. PubMed ID: 28128085
[TBL] [Abstract][Full Text] [Related]
4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
5. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?
IJdo JW; Conti-Kelly AM; Greco P; Abedi M; Amos M; Provenzale JM; Greco TP
Lupus; 1999; 8(2):109-15. PubMed ID: 10192504
[TBL] [Abstract][Full Text] [Related]
6. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?
Karussis D; Leker RR; Ashkenazi A; Abramsky O
Ann Neurol; 1998 Oct; 44(4):629-34. PubMed ID: 9778261
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
[TBL] [Abstract][Full Text] [Related]
8. Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics.
Heinzlef O; Weill B; Johanet C; Sazdovitch V; Caillat-Zucman S; Tournier-Lasserve E; Roullet E
J Neurol Neurosurg Psychiatry; 2002 May; 72(5):647-9. PubMed ID: 11971055
[TBL] [Abstract][Full Text] [Related]
9. Do patients followed in anticoagulation clinics for antiphospholipid syndrome meet criteria for the disorder?
Dunn AS; Kaboli P; Halfdanarson T; Chan H; Hubert R; Rosen S; White RH
Thromb Haemost; 2005 Sep; 94(3):548-54. PubMed ID: 16268471
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
11. Anticardiolipin antibodies in MS patients.
Scott F; Brillman I; Romanelli I; Hess D
Acta Neurol Scand; 1994 Nov; 90(5):374-5. PubMed ID: 7887140
[No Abstract] [Full Text] [Related]
12. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?
Ferreira S; D'Cruz DP; Hughes GR
Rheumatology (Oxford); 2005 Apr; 44(4):434-42. PubMed ID: 15644391
[TBL] [Abstract][Full Text] [Related]
15. Anticardiolipin antibodies in Japanese patients with multiple sclerosis.
Fukazawa T; Moriwaka F; Mukai M; Hamada T; Koike T; Tashiro K
Acta Neurol Scand; 1993 Sep; 88(3):184-9. PubMed ID: 8256554
[TBL] [Abstract][Full Text] [Related]
16. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
[TBL] [Abstract][Full Text] [Related]
17. Discordance between anti-beta2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome.
Micheloud D; Sánchez-Ramón S; Carbone J; Rodríguez Molina JJ; Fernández-Cruz E; López-Longo FJ; Rodríguez-Mahou M
Clin Exp Rheumatol; 2005; 23(4):525-8. PubMed ID: 16095124
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
19. Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I.
Greco TP; Amos MD; Conti-Kelly AM; Naranjo JD; Ijdo JW
Lupus; 2000; 9(1):33-41. PubMed ID: 10713645
[TBL] [Abstract][Full Text] [Related]
20. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis.
Sanmarco M; Roll P; Gayet S; Oksman F; Johanet C; Escande A; Cohen JH; Chevailler A; Goetz J; Humbel RL; Sibilia J
J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
